QuidelOrtho Appoints Abbott Laboratories Executive as Next CEO
By Denny Jacob QuidelOrtho said Thursday that Brian Blaser has been appointed as its next chief executive. The in-vitro diagnostic technologies provider said Blaser, who was also appointed presiden
WSJMay 2 08:41 ET
QuidelOrtho Blaser's Appointment Effective May 6
QuidelOrtho Blaser's Appointment Effective May 6
Dow JonesMay 2 08:03 ET
QuidelOrtho Board Expanding To 11 Members From 10 Members >QDEL
QuidelOrtho Board Expanding To 11 Members From 10 Members >QDEL
Dow JonesMay 2 08:03 ET
Express News | QuidelOrtho Appoints Brian J. Blaser as President and Chief Executive Officer
ReutersMay 2 08:00 ET
We Think QuidelOrtho (NASDAQ:QDEL) Is Taking Some Risk With Its Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' It's only natural to co
Simply Wall StMay 2 06:47 ET
RBC Capital Remains a Buy on QuidelOrtho (QDEL)
TipRanksApr 30 21:49 ET
Express News | QuidelOrtho Corporation : Craig-Hallum Cuts Target Price to $40 From $50
Moomoo 24/7Apr 22 12:56 ET
QuidelOrtho To Report First Quarter 2024 Financial Results
QuidelOrtho Corporation (NASDAQ:QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine,
BusinesswireApr 17 07:00 ET
Express News | QuidelOrtho Adds Fentanyl Test To Its Vitros Systems As A MicroTip Partnership Assay To Help Hospital And Emergency Room Customers Allow On-site Fentanyl Testing In Less Than 10 Minutes
Moomoo 24/7Apr 10 07:09 ET
QuidelOrtho Adds Fentanyl Test to Its Vitros Systems as a MicroTip Partnership Assay
QuidelOrtho Corporation (Nasdaq: QDEL) has added the ARK Fentanyl II Assay to its U.S. Vitros XT 7600 and 5600 Integrated Systems as well as its Vitros 4600 Chemistry System menu of assays as a MicroTip Partnership Assay ("MPA"). This Fentanyl assay will help hospital and emergency room customers respond to the critical demand for enhanced opioid testing, allowing on-site fentanyl testing in less than 10 minutes to aid in immediate clinical decisions.
BusinesswireApr 10 07:00 ET
RBC Capital Reaffirms Their Buy Rating on QuidelOrtho (QDEL)
TipRanksApr 8 21:46 ET
This QuidelOrtho Insider Increased Their Holding By 54% Last Year
Yahoo FinanceApr 3 15:44 ET
QuidelOrtho's (QDEL) QuickVue Gets FDA Nod for COVID Testing
Yahoo FinanceApr 3 10:48 ET
What's Going With COVID-19 Test Maker QuidelOrtho Stock On Tuesday?
On Tuesday, QuidelOrtho Corporation (NASDAQ:QDEL) received FDA 510(k) clearance for its QuickVue COVID-19 test. This clearance allows the test to be used accurately and conveniently in home and medica
BenzingaApr 2 13:05 ET
Express News | QuidelOrtho Shares Are Trading Lower. The Company Announced It Will Withdraw the Current FDA 510(k) Submission for Its Savanna RVP4+ Assay
Moomoo 24/7Apr 2 12:29 ET
Express News | RBC Out With Note On QuidelOrtho Saying "After Speaking To Management No Change At QuidelOrtho; Company Withdraws Original Savanna RVP4+ Assay From FDA 510(k) Submission, Plans Resubmission Ahead Of 2024/2025 Respiratory Season
Moomoo 24/7Apr 2 12:19 ET
Update: QuidelOrtho Shares Fall on Decision to Withdraw FDA 510(k) Submission for Savanna RVP4+ Assay
(Updates with the latest stock price movement and withdrawal of RVP4+ assay 510(k) submission.) QuidelOrtho (QDEL) shares were down 9.6% in recent Tuesday trading after the company said it decided to
MT NewswiresApr 2 12:00 ET
Express News | QuidelOrtho Receives FDA Clearance For QuickVue COVID-19 Test
Moomoo 24/7Apr 2 09:01 ET
Ford, Envista Holdings, and Alaska Air Are Among Additions to GS' Short Duration List
Seeking AlphaMar 28 13:49 ET
The Past Three Years for QuidelOrtho (NASDAQ:QDEL) Investors Has Not Been Profitable
If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But the long term shareholders of QuidelOrtho Corporation (NASDAQ:QDEL) have had an
Simply Wall StMar 27 06:56 ET
No Data
No Data